MBX Biosciences, Inc. MBX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Mbx Biosciences Inc. is a biopharmaceutical company focused on the research and development of innovative endocrine therapeutics. It strives to address unmet medical needs through pioneering treatments for endocrine disorders. The company's central aim is to develop precision endocrinology therapies, leveraging proprie…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees63
TickerMBX
Statistics
Market Cap$1.98B
Revenue (TTM)—
Net Income-$87.0M
Net Margin—
EPS$-2.38
P/E3.74
P/S—
P/B3.30
EV/EBITDA-9.97
ROE-25.7%
Dividend Yield—
Price$41.53
Data: Twelve Data · Revenue = mcap / P/S